FGF7 (Fibroblast Growth Factor 7), also known as keratinocyte growth factor (KGF), is a member of the fibroblast growth factor family that functions primarily as a paracrine growth factor. Unlike other FGFs that bind multiple FGFR isoforms with high affinity, FGF7 exhibits specificity for FGFR2 (particularly the FGFR2-IIIb isoform) and FGFR1-IIIb, making it a targeted ligand for epithelial and certain neuronal cells.
Located on chromosome 19p13.3, the FGF7 gene encodes a 194-amino acid secreted protein with a molecular weight of approximately 26 kDa. The protein contains a typical FGF homology domain flanked by N-terminal and C-terminal regions that contribute to receptor specificity and heparin binding.
FGF7 is expressed in various tissues including skin, lung, gastrointestinal tract, and brain, where it plays critical roles in tissue repair, morphogenesis, and cellular survival. In the nervous system, FGF7 is produced by astrocytes and neurons, where it supports neural progenitor cell proliferation, neuronal survival, and synaptic function. Growing evidence links FGF7 to neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
| Property |
Value |
| Gene Symbol |
FGF7 |
| Full Name |
Fibroblast Growth Factor 7 |
| Alternative Names |
KGF (Keratinocyte Growth Factor) |
| Chromosomal Location |
19p13.3 |
| NCBI Gene ID |
2254 |
| Ensembl ID |
ENSG00000145681 |
| UniProt ID |
P21781 |
| OMIM |
148180 |
| Protein Type |
Secreted growth factor |
| Molecular Weight |
~26 kDa |
| Associated Diseases |
Alzheimer's disease, Parkinson's disease |
FGF7 signals through a restricted set of receptors:
- FGFR2-IIIb (FGFR2b): Primary high-affinity receptor, epithelial-specific
- FGFR1-IIIb (FGFR1b): Lower affinity alternative
Upon FGFR2b binding, FGF7 activates multiple downstream signaling pathways:
- RAS/MAPK pathway: Promotes cell proliferation and differentiation
- PI3K/AKT pathway: Mediates cell survival and anti-apoptotic effects
- PLCγ pathway: Regulates calcium signaling and cytoskeletal reorganization
FGF7 (Keratinocyte Growth Factor) exhibits the following biological functions:
- Epithelial growth and maintenance: Promotes epithelial cell proliferation and differentiation
- Tissue repair: Critical for wound healing through fibroblast migration and epithelialization
- Lung development: Essential for alveolar epithelial cell development
- Gastrointestinal function: Supports intestinal epithelial homeostasis
- Neuroprotection: Exhibits neurotrophic properties in the central nervous system
¶ Brain Expression and Function
FGF7 is expressed in multiple tissues and in the brain:
- Hippocampus: Moderate expression in dentate gyrus and CA regions
- Cerebral cortex: Present in cortical neurons and glia
- Subventricular zone: Neural stem cells produce FGF7
FGF7 is produced by multiple cell types in the brain:
- Astrocytes: Primary source of neuronal FGF7
- Neurons: Autocrine and paracrine signaling
- Oligodendrocyte progenitors: Support of myelination
FGF7 is implicated in AD through multiple mechanisms:
Neuroprotection: FGF7 protects neurons against Aβ-induced toxicity through activation of FGFR2 and downstream signaling cascades involving PI3K/Akt and MAPK pathways.
Neural stem cell support: FGF7 promotes proliferation of neural stem cells in the subventricular zone and hippocampus, potentially supporting endogenous repair mechanisms.
Tau pathology interaction: FGF7 signaling may be affected by tau pathology, and conversely, FGF7 can modulate tau phosphorylation through GSK3β regulation.
Synaptic function: FGF7 supports synaptic maintenance and plasticity, which are compromised in AD.
FGF7 contributes to PD through several mechanisms:
Dopaminergic neuron survival: FGF7 promotes survival of dopaminergic neurons in the substantia nigra, protecting against MPTP and 6-OHDA toxicity.
Neuroinflammation modulation: FGF7 can modulate microglial activation and reduce inflammatory responses that contribute to dopaminergic degeneration.
Neural regeneration: FGF7 supports migration and differentiation of neural progenitors that could replace lost neurons.
FGF7 protects neurons through:
- Upregulation of Bcl-2 family proteins
- Inhibition of caspase activation
- Preservation of mitochondrial integrity
- Reduction of oxidative stress
FGF7 modulates neuroinflammation:
- Reduction of pro-inflammatory cytokine production
- Modulation of microglial activation states
- Protection of neurons from inflammatory damage
FGF7 supports synaptic function:
- Maintenance of dendritic spine density
- Preservation of synaptic protein expression
- Support of long-term potentiation
FGF7 delivery represents a promising therapeutic approach:
- AAV vectors: Effective delivery to brain parenchyma
- Protein delivery: Recombinant FGF7 can cross blood-brain barrier in some formulations
FGF7 as a biomarker:
- CSF FGF7 levels: May correlate with disease progression
- Peripheral FGF7: Potential non-invasive marker
¶ Interactions and Signaling Network
FGF7 interacts with multiple pathways:
| Pathway |
Interaction |
Function |
| FGFR2 |
Direct binding |
Primary signaling |
| Heparan sulfate |
Required for signaling |
Co-receptor |
| PI3K/Akt |
Downstream pathway |
Survival |
| MAPK/ERK |
Downstream pathway |
Proliferation |
FGF7 initiates signaling through a well-characterized cascade:
- Receptor binding: FGF7 binds specifically to FGFR2-IIIb (FGFR2b), the epithelial isoform of FGFR2
- Dimerization: ligand binding induces receptor dimerization and autophosphorylation
- Downstream activation: Multiple intracellular pathways are activated
The downstream signaling involves:
- RAS/RAF/MEK/ERK pathway: Controls cell proliferation and differentiation
- PI3K/AKT pathway: Mediates cell survival and anti-apoptotic signaling
- PLCγ pathway: Regulates calcium signaling and cytoskeletal reorganization
During neural development:
- FGF7 is expressed in the ventricular zone and subventricular zone
- Peak expression occurs during periods of active neurogenesis
- Astrocytes are the primary source of FGF7 in the developing brain
FGF7 promotes neural progenitor cell proliferation and differentiation:
- Proliferation: FGFR2 signaling stimulates cell cycle progression
- Differentiation: Supports transition from progenitors to post-mitotic neurons
- Survival: Anti-apoptotic signaling protects developing neurons
FGFR2 (particularly the IIIb isoform) is expressed in:
- Cortical neurons
- Hippocampal pyramidal cells
- Cerebellar Purkinje cells
- Substantia nigra dopaminergic neurons
While FGF7 has lower affinity for FGFR1-IIIb, this receptor is more widely expressed and can mediate FGF7 effects in some neuronal populations.
FGF7 protects neurons through multiple mechanisms:
- Bcl-2 family upregulation: Increased expression of anti-apoptotic Bcl-2 and Bcl-xL
- Caspase inhibition: Reduced activation of caspase-3 and caspase-9
- Mitochondrial protection: Preservation of mitochondrial membrane potential
- DNA repair enhancement: Support for DNA repair mechanisms
FGF7 reduces oxidative stress:
- Upregulation of antioxidant enzymes (SOD, catalase, glutathione peroxidase)
- Reduction of lipid peroxidation
- Protection against ROS-induced damage
FGF7 modulates neuroinflammation:
- Inhibition of microglial activation
- Reduced pro-inflammatory cytokine production (IL-1β, TNF-α, IL-6)
- Promotion of anti-inflammatory cytokine expression
Several therapeutic strategies are being developed:
- Recombinant FGF7 protein: For direct protein delivery
- Small molecule FGFR agonists: Brain-penetrant compounds
- Gene therapy vectors: AAV-mediated FGF7 expression
FGF7 is used in research to:
- Promote neuronal survival in culture
- Study FGFR signaling mechanisms
- Develop neuroprotective drug screens
FGF7 plays essential roles during embryonic neural development:
Neural Plate Formation:
- FGF7 signaling influences early neural specification
- Regulates the transition from ectoderm to neural tissue
- Cooperates with other FGF family members in neural induction
Brain Regionalization:
- FGF7/FGFR2 signaling contributes to forebrain development
- Regulates patterning of the cerebral cortex
- Influences hippocampal formation
Neuronal Progenitor Maintenance:
- FGF7 maintains neural progenitor cell populations
- Prevents premature neuronal differentiation
- Supports expansion of neural precursor pools
In the adult brain, FGF7 continues to play important roles:
Subventricular Zone:
- FGF7 produced by astrocytes supports neural stem cells
- Promotes proliferation of transit-amplifying cells
- Regulates neuroblast migration to olfactory bulb
Hippocampal Dentate Gyrus:
- FGF7 influences adult hippocampal neurogenesis
- Supports survival of newly generated neurons
- Regulates synaptic integration of new neurons
FGF7 also affects glial cell development:
Astrocyte Differentiation:
- FGF7 signaling promotes astrocyte lineage specification
- Regulates astrocyte proliferation and maturation
- Influences astrocyte morphological complexity
Oligodendrocyte Development:
- FGF7 supports oligodendrocyte progenitor survival
- Regulates myelination processes
- Affects oligodendrocyte differentiation
FGF7 significantly affects microglial function:
Activation State Regulation:
- FGF7 can shift microglial polarization toward anti-inflammatory phenotype
- Reduces production of pro-inflammatory cytokines
- Promotes expression of anti-inflammatory mediators
Phagocytic Activity:
- Modulates microglial phagocytosis of debris
- Affects clearance of apoptotic cells
- Regulates synaptic pruning processes
Migration and Proliferation:
- Influences microglial migration patterns
- Controls microglial proliferation in response to injury
- Affects microglial recruitment to lesion sites
FGF7 modulates astrocyte responses to injury:
Reactive Astrocytosis:
- Regulates the magnitude of astrocyte reactivity
- Influences scar formation dynamics
- Affects expression of glial fibrillary acidic protein (GFAP)
Neuroprotective Functions:
- Promotes astrocyte secretion of neurotrophic factors
- Enhances astrocyte support of neuronal survival
- Modulates astrocyte metabolic support
¶ FGF7 and Synaptic Plasticity
FGF7 plays important roles in LTP:
Synaptic Strength:
- FGF7 signaling enhances synaptic transmission
- Promotes AMPA receptor trafficking to synapses
- Modulates NMDA receptor function
Molecular Mechanisms:
- FGFR2 activation leads to MAPK/ERK pathway activation
- PI3K/Akt signaling contributes to synaptic strengthening
- CREB-mediated gene transcription supports LTP maintenance
FGF7 also affects LTD:
Synaptic Depression:
- Modulates AMPA receptor internalization
- Affects protein phosphatase activity
- Influences endocannabinoid signaling
FGF7 supports structural changes at synapses:
Dendritic Spines:
- Promotes spine formation and maturation
- Regulates spine morphology
- Affects spine density changes during learning
Axonal Boutons:
- Modulates presynaptic terminal size
- Affects vesicle pool characteristics
- Influences active zone organization
FGF7 therapeutic approaches for neurodegenerative diseases:
Alzheimer's Disease:
- AAV-FGF7 delivery to hippocampus
- Combination with anti-amyloid therapies
- Targeting of neural stem cell niches
Parkinson's Disease:
- FGF7 delivery to substantia nigra
- Protection of dopaminergic neurons
- Support of grafted cell survival
Amyotrophic Lateral Sclerosis:
- Motor neuron protection
- Support of neuromuscular junction
- Modulation of glial responses
Effective FGF7 delivery methods:
| Method |
Advantages |
Challenges |
| AAV vectors |
Long-term expression |
Immune response |
| Protein injection |
Direct delivery |
Short half-life |
| Small molecules |
Oral availability |
Limited potency |
| Cell therapy |
Site-specific |
Manufacturing |
FGF7 as a biomarker:
Diagnostic Markers:
- CSF FGF7 levels in neurodegenerative diseases
- Peripheral blood FGF7 measurements
- Correlation with disease severity
Progression Markers:
- Longitudinal changes in FGF7 expression
- Treatment response indicators
- Prognostic value in disease courses
FGF7 functions in hippocampal circuits:
CA1 Region:
- Supports pyramidal neuron survival
- Modulates synaptic plasticity
- Affects memory consolidation
Dentate Gyrus:
- Regulates neural stem cell activity
- Supports granule cell neurogenesis
- Influences pattern separation
Cortical functions of FGF7:
Layer-Specific Effects:
- Different FGF7 responses across cortical layers
- Regulation of interneuron development
- Control of pyramidal neuron maturation
Cortical Connectivity:
- Affects axonal projection development
- Modulates synapse formation
- Supports cortical circuit maturation
FGF7 in cerebellar function:
Purkinje Cells:
- Supports Purkinje cell survival
- Regulates dendritic arborization
- Modulates synaptic plasticity
Granule Cells:
- Promotes granule cell development
- Affects migration patterns
- Supports inhibitory circuit formation
FGF7 activates multiple signaling pathways:
RAS/MAPK Pathway:
- RAF → MEK → ERK cascade
- Controls cell proliferation and differentiation
- Regulates gene expression programs
PI3K/AKT Pathway:
- Promotes cell survival
- Inhibits apoptosis
- Supports metabolic functions
PLCγ Pathway:
- Calcium signaling modulation
- Cytoskeletal reorganization
- Protein kinase C activation
FGF7 interacts with numerous signaling networks:
Wnt/β-catenin:
- Synergistic effects on neural stem cells
- Shared target genes
- Cooperative neuroprotection
Notch Signaling:
- Cross-regulation of differentiation
- Shared progenitor cell effects
- Opposing functions in some contexts
Hedgehog Pathway:
- Complementary effects on neurogenesis
- Coordinated patterning functions
- Combined therapeutic potential
¶ Genetic and Pharmacological Modulation
Modulating FGF7 expression:
Overexpression:
- AAV-mediated FGF7 gene delivery
- Inducible expression systems
- Cell-type specific promoters
Knockdown:
- shRNA-mediated reduction
- CRISPR interference approaches
- Antisense oligonucleotide strategies
Small molecule approaches:
FGFR Agonists:
- Recombinant FGF7 protein
- Small molecule FGFR2 activators
- Stabilized FGF7 variants
FGFR Antagonists:
- FGFR blocking antibodies
- Tyrosine kinase inhibitors
- Decoy receptor approaches
| Model |
Applications |
Advantages |
| Primary neurons |
Mechanism studies |
Physiological |
| Neural stem cells |
Proliferation |
Expandable |
| Organoids |
Development |
3D structure |
| iPSC neurons |
Disease modeling |
Patient-specific |
Mouse Models:
- FGF7 transgenic overexpression
- Conditional knockout systems
- Disease model crosses
Zebrafish:
- Live imaging capabilities
- Genetic tractability
- Developmental studies
Non-human Primates:
- Translational relevance
- Complex brain functions
- Therapeutic testing
Current development stage:
- AAV-FGF7: Preclinical validation
- Recombinant protein: Formulation optimization
- Small molecules: Lead identification
Future clinical applications:
- Biomarker validation
- Dose-finding studies
- Patient selection criteria
- Combination therapy protocols
Key questions in FGF7 research:
- What determines cell-type specific responses to FGF7?
- How can neuroprotective effects be separated from other functions?
- What are optimal delivery strategies for different diseases?
- Can FGF7 be combined safely with other therapies?
New research directions:
- Engineered FGF7 variants with enhanced properties
- Cell-specific targeting strategies
- Biomarker development for patient selection
- Combination therapy protocols